Overall, AMPs offer a promising avenue for treating parasitic diseases and NTDs, providing both direct antimicrobial effects and potential synergistic activity, which could help address the growing challenge of drug-resistant parasites. This evidence concerns the gene ADSL and parasitic infectious disease.